Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.
Witzel S, Huss A, Nagel G, Rosenbohm A, Rothenbacher D, Peter RS, Bäzner H, Börtlein A, Dempewolf S, Schabet M, Hecht M, Kohler A, Opherk C, Naegele A, Sommer N, Lindner A, Alexudis C, Bachhuber F, Halbgebauer S, Brenner D, Ruf W, Weiland U, Mayer B, Schuster J, Dorst J, Tumani H, Ludolph AC; and the ALS Registry Swabia Study Group. Witzel S, et al. Among authors: opherk c. Ann Neurol. 2024 Dec;96(6):1040-1057. doi: 10.1002/ana.27054. Epub 2024 Aug 23. Ann Neurol. 2024. PMID: 39177232
Epidemiology of amyotrophic lateral sclerosis in Southern Germany.
Rosenbohm A, Peter RS, Erhardt S, Lulé D, Rothenbacher D, Ludolph AC, Nagel G; ALS Registry Study Group. Rosenbohm A, et al. J Neurol. 2017 Apr;264(4):749-757. doi: 10.1007/s00415-017-8413-3. Epub 2017 Feb 20. J Neurol. 2017. PMID: 28220290
Coping as a resource to allow for psychosocial adjustment in fatal disease: results from patients with amyotrophic lateral sclerosis.
Finsel J, Rosenbohm A, Peter RS, Bäzner H, Börtlein A, Dempewolf S, Schabet M, Hecht M, Kohler A, Opherk C, Nägele A, Sommer N, Lindner A, Rothenbacher D, Ludolph AC, Nagel G, Lulé DE. Finsel J, et al. Among authors: opherk c. Front Psychol. 2024 Apr 4;15:1361767. doi: 10.3389/fpsyg.2024.1361767. eCollection 2024. Front Psychol. 2024. PMID: 38638511 Free PMC article.
Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value.
Nagel G, Kurz D, Peter RS, Rosenbohm A, Koenig W, Dupuis L, Bäzner H, Börtlein A, Dempewolf S, Schabet M, Hecht M, Kohler A, Opherk C, Naegele A, Sommer N, Lindner A, Tumani H, Ludolph AC, Rothenbacher D. Nagel G, et al. Among authors: opherk c. Sci Rep. 2023 Nov 10;13(1):19594. doi: 10.1038/s41598-023-46179-9. Sci Rep. 2023. PMID: 37949878 Free PMC article.
Phenotyping of the thoracic-onset variant of amyotrophic lateral sclerosis.
Kandler K, Witzel S, Eder K, Rothenbacher D, Nagel G, Peter RS, Schuster J, Dorst J, Rosenbohm A, Ludolph AC; ALS Registry Study Group. Kandler K, et al. J Neurol Neurosurg Psychiatry. 2022 May;93(5):563-565. doi: 10.1136/jnnp-2021-326712. Epub 2021 Oct 19. J Neurol Neurosurg Psychiatry. 2022. PMID: 34667101 No abstract available.
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial.
Frey BM, Boutitie F, Cheng B, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Ford I, Galinovic I, Königsberg A, Puig J, Roy P, Wouters A, Magnus T, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G; WAKE-UP investigators. Frey BM, et al. Neurol Res Pract. 2020 Nov 20;2:40. doi: 10.1186/s42466-020-00087-9. eCollection 2020. Neurol Res Pract. 2020. PMID: 33324940 Free PMC article.
77 results